Value Management Office (VMO) — MedTech & Life Sciences Portfolio

Your Role

The VMO is a senior value-creation leader responsible for converting investment theses into measurable EBITDA and enterprise-value outcomes across Graham Partners healthcare medtech and life sciences portfolio. The role sets the strategic operating cadence that links deal-thesis priorities to execution and benefits realizationensuring every portfolio company moves with the speed and discipline our hold period demands.

Operating at the intersection of strategy and operations the VMO partners directly with portfolio-company CEOs and Chief Transformation Officers to shape value-creation roadmaps develop the underlying business cases and transformation agenda and accelerate commercial and operational execution. The role de-risks the challenges that define contract manufacturing for regulated end markets: FDA and quality-system readiness (21 CFR 820 ISO 13485 ISO 9001) customer audits and complaint/CAPA performance OEM customer concentration and program ramp manufacturing scale-up and capacity planning supplier and materials risk and M&A integration of operations quality and commercial functions.

The VMO coordinates closely with GPOCs functional pillarsFinance Value Creation Operating Value Creation Technology & AI and ESG & Complianceand serves as the central nerve center connecting investment teams portfolio leadership and external advisors around a shared view of value at risk and value created.

Strategic Mandate

• Translate investment theses into value-creation plans. Convert deal-thesis priorities into prioritized sequenced and resourced value-creation roadmaps that reflect the realities of CDMO and regulated-manufacturing operating environmentsOEM customer program cycles FDA and quality-system constraints capacity and capital-equipment lead times and supplier qualification timelines.
• Institutionalize value-creation discipline across the portfolio. Stand up and scale a portfolio-wide operating systemgovernance KPIs integrated roadmaps and a single source of truthacross priority portfolio companies (initial target: 8 portcos onboarded) with a goal of measurable reportable EBITDA and enterprise-value impact.
• Drive execution where it matters most. Ensure 90% of priority initiatives have named accountable owners defined KPIs with baselines milestone-based plans and disciplined monthly performance reviews tied to value capture vs. plan.
• Surface the portfolio view. Build and maintain integrated cross-initiative roadmaps that expose interdependencies capacity constraints regulatory dependencies and capital needsgiving Operating Partners and the Investment Committee a real-time decision-grade picture of portfolio health.
• Make value visible. Deliver board-ready dashboards and Investment Committee narratives that translate operating progress into enterprise-value language: EBITDA bridge multiple expansion drivers value-at-risk and benefits realization vs. underwriting.

Core Responsibilities

• Value-creation strategy & portfolio governance. Architect the VMO operating modelsteering committees working sessions escalation paths and decision rightsthat connects investment thesis to execution. Define the operating playbook used across the healthcare portfolio.
• Program design & integrated planning. Partner with portco leadership and GPOC operating partners to scope high-impact initiatives across commercial growth and customer expansion operational excellence and plant productivity quality and regulatory readiness manufacturing scale-up and capacity planning supply chain and supplier qualification and digital/AI transformation. Consolidate into an integrated portfolio view with clear sequencing and capital implications.
• Benefits realization & performance management. Own the value-tracking framework end-to-end: baseline definition KPI design value attribution and outcome reporting. Hold initiative owners accountable for outcomesnot activityat both the portco and portfolio level.
• Risk regulatory & interdependency management. Identify cross-functional risks earlyparticularly those unique to CDMOs serving regulated end markets (FDA inspections customer quality audits CAPA and complaint trends recalls OEM customer concentration program ramp delays sole-source supplier exposure and capacity bottlenecks). Drive structured mitigation scenario planning and decision paths to Operating Partners and the Investment Committee.
• M&A integration & carve-out execution. Support add-on integrations and carve-outs by embedding VMO discipline into Day 1 and 100-day plans with particular attention to integrating quality systems regulatory filings commercial and operations functions.
• Enablement tooling & ways of working. Lead deployment and adoption of GPOCs PMO platform (Conductor) and value-management standards across portcos. Coach portco leadership teams on operating mechanisms performance cadences and value-creation best practices.
• Stakeholder engagement & C-suite partnership. Operate as a trusted advisor to portco CEOs and Chief Transformation Officers with regular partnership across Chief Operating Officers and Chief Commercial Officers; coordinate with the Finance Value Creation team on CFO-facing workstreams. Align deal teams functional operating partners and external advisors around a shared agenda and crisp outcome-oriented communication.
• Portfolio-company interface. Work in lock-step with each portcos transformation leader (e.g. Chief Value Acceleration Lead CVAL) to embed operating cadence measure impact escalate the right issues at the right time and ensure value-creation plans remain dynamic and grounded in commercial and regulatory reality.

We seek top-tier talent with the following qualifications:

• CDMO contract manufacturing or life sciences depth. Direct experience driving value creation transformation or operating leadership within CDMOs medical device contract manufacturing diagnostics pharma services or other regulated manufacturing businesses serving OEM customers. Working familiarity with FDA regulatory pathways and quality systems (21 CFR 820 ISO 13485 ISO 9001) customer audit dynamics and OEM commercial relationships is strongly preferred.
• 10 years driving complex cross-functional value creation. Background in top-tier strategy consulting PE operations or enterprise transformation leadershipwith a track record of aligning strategy capital and execution across multiple programs or business units.
• Portfolio-grade governance and measurement. Demonstrated success standing up VMO/PMO operating systems KPI architectures and portfolio-management tooling across multiple companies or business unitstranslating ambiguous strategic intent into measurable governed execution.
• Financial and commercial fluency. Strong command of EBITDA bridges value-creation modeling business-case quantification and executive-ready reporting. Comfortable interrogating operating KPIs and commercial metrics with portco leadership and Operating Partners and partnering with Finance Value Creation on financial deep-dives.
• Executive presence and influence. High EQ and proven ability to earn trust and drive action with C-suite leaders founder-led management teams deal partners and functional expertsoften without direct authority.
• Bias for outcomes. Operates with intellectual honesty about what is working and what is not; willing to challenge sacred cows reset plans and hold the line on accountability.

Tools & Methods

• PMO and portfolio tools: Conductor (primary) supported by GPOCs standard VMO templates dashboards and value-tracking frameworks.
• Operating framework: GPOCs end-to-end value-creation methodology across the deal lifecyclediagnostic definition planning execution and sustainmenttailored to the regulatory manufacturing and commercial dynamics of CDMO and life sciences investing.

Travel:

• Periodic travel to portfolio companies manufacturing sites and customer or commercial operations based on program needs and value-creation priorities.

We Offer Competitive Compensation & Benefits:

• Comprehensive health benefits package including medical dental and vision
• 401(k)
• Opportunity for a hybrid office schedule
• Paid firmwide holidays
• Ongoing training
• Wellness stipend / Fitler Club membership
• Paid parental leave